Analyst Viewpoint
Rise in prevalence of H. pylori infection and advancements in PCR technology are fueling the Helicobacter pylori (H. pylori) non-invasive testing market size. Low diagnosis rates, asymptomatic nature of infection, and are expected to hamper the market landscape in the near future.
H. pylori infection is very common among children, particularly in developing countries and regions with poor sanitation and overcrowded living conditions.
Key players operating in the Helicobacter pylori (H. pylori) non-invasive testing market landscape are developing tests that offer quick and accurate results enabling healthcare professionals to make informed decisions about patient care.
Helicobacter pylori (H. pylori) is a spiral-shaped gram-negative aerobic bacterium that infects the stomach. When H. pylori infects the stomach lining, it results in stomach infections.
Such infections generally lead to peptic ulcers and gastritis and are additionally associated with stomach, duodenal, and gastric cancers. This kind of infection is found in men, women, and even children. Over 50% of the world's population is infected by H. pylori.
H. pylori infection is an asymptomatic infection that requires professional diagnosis. Peptic ulcers are usually caused due to H. pylori and some of the most common symptoms of the infection include vomiting, abdominal pain, nausea, loss of appetite, and excessive burping.
H. pylori infection is very common among children. In some cases, peptic ulcers lead to serious complications such as obstruction in the stomach lining, internal bleeding, or perforation.
According to a study published in the Journal of Family Medicine and Primary Care in 2022, the prevalence rates of H. pylori among male and female patients were 32.3% and 32.7%, respectively. The prevalence rate of H. pylori was highest among patients aged between 41 and 60 years (38.7%) and lowest among those aged over 60 years (19.5%).
The most important risk factors include being male, poor adherence or difficult access to treatment, and the lack of in-home water service. The prevalence of H. pylori in children without gastrointestinal who underwent screening was reported to be only 14.2% in Africa.
Some of the major factors are having a traditional pit or no toilet, poverty, birth order, source of drinking water, or being a farmer. These factors are expected to spur the Helicobacter pylori (H. pylori) non-invasive testing market growth in the near future.
Asia Pacific seems to have the widest variations in terms of H. pylori prevalence and is associated with as lower income and educational level, house crowding, rural residence, ethnicity, the use of tanks as water supplies, alcohol drinking, active smoking, eating spicy food or raw uncooked vegetables, and poor living conditions and sanitation.
Thus, absence of personal hygiene and poor sanitation are propelling the Helicobacter pylori (H. pylori) non-invasive testing market demand.
Polymerase Chain Reaction (PCR) is largely employed to detect gastric biopsies, dental plaque, and feces to further improve invasive approaches for disease diagnosis. PCR enhances the diagnosis of H. pylori infection in non-bleeding conditions.
Development and launch of advanced PCR-based testing methods is driving the Helicobacter pylori (H. pylori) non-invasive testing industry expansion.
In 2020, Becton, Dickinson, and Company launched its new BD MAX H. pylori non-invasive molecular diagnostic test that employs PCR technology to detect H. pylori DNA in stool specimens. The test provides quick and accurate results, offering a highly efficient diagnostic tool for H. pylori infections.
According to latest Helicobacter pylori (H. pylori) non-invasive testing market trends, North America held the largest share in 2022. Increase in adoption of non-invasive testing methods and heightened prevalence of H. pylori infection are fueling the market dynamics of the region.
According to the Centers for Disease Control and Prevention, 35%-40% of the population in the U.S. is affected by H. pylori. Furthermore, approval of various non-invasive tests for the detection and diagnosis of H. pylori infections, including stool antigen tests and breath tests, are also bolstering the Helicobacter pylori (H. pylori) non-invasive testing market share in North America.
Many individuals infected with H. pylori may not exhibit any symptoms. They may not seek medical attention, leading to underdiagnosis and undertreatment of the infection. This, in turn, is expected to limit the market revenue in the next few years.
To overcome these issues, government organizations and manufacturers of Helicobacter pylori (H. pylori) non-invasive testing solutions are promoting diseases awareness. Manufacturers are developing tests that offer quick and accurate results enabling healthcare professionals to make informed decisions about patient care.
DiaSorin S.p.A., Meridian Bioscience, Inc., Exalenz Bioscience Ltd., Abbott, Thermo Fisher Scientific, Biomerica, Inc., Certest Biotec S.L., Sekisui Diagnostics, Coris Bioconcept, and Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.
These companies have been profiled in the Helicobacter pylori (H. pylori) non-invasive testing market report based on various parameters including company overview, business segments, product portfolio, recent developments, business strategies, and financial overview.
| Attribute | Detail |
|---|---|
| Market Size in 2022 | US$ 549.6 Mn |
| Market Forecast (Value) in 2031 | US$ 788.2 Mn |
| Growth Rate (CAGR) | 4.2% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2021 |
| Quantitative Tons | US$ Mn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces Analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
It was valued at US$ 549.6 Mn in 2022
It is anticipated to grow at a CAGR of 4.2% from 2023 to 2031
Rise in prevalence of H. Pylori infection and advancements in PCR technology
North America was the leading region in 2022
DiaSorin S.p.A., Meridian Bioscience, Inc., Exalenz Bioscience Ltd., Abbott, Thermo Fisher Scientific, Biomerica, Inc., Certest Biotec S.L., Sekisui Diagnostics, Coris Bioconcept, and Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Analysis and Forecast, by Test Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Test Type, 2017–2031
6.3.1. Serology Test
6.3.2. Stool Antigen Test (SAT)
6.3.3. Urea Breath Test (UBT)
6.4. Market Attractiveness Analysis, by Test Type
7. Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Analysis and Forecast, by Test Method
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Test Method, 2017–2031
7.3.1. Laboratory-based Tests
7.3.2. Point-of-Care Tests
7.4. Market Attractiveness Analysis, by Test Method
8. Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Clinics
8.3.3. Diagnostic Laboratories
8.4. Market Attractiveness Analysis, by Test Method
9. Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017–2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Test Type, 2017–2031
10.3.1. Serology Test
10.3.2. Stool Antigen Test (SAT)
10.3.3. Urea Breath Test (UBT)
10.4. Market Value Forecast, by Test Method, 2017–2031
10.4.1. Laboratory-based Tests
10.4.2. Point-of-Care Tests
10.5. Market Value Forecast, by End-user, 2017–2031
10.5.1. Hospitals
10.5.2. Clinics
10.5.3. Diagnostic Laboratories
10.6. Market Value Forecast, by Country, 2017–2031
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Test Type
10.7.2. By Test Method
10.7.3. By End-user
10.7.4. By Country
11. Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Test Type, 2017–2031
11.3.1. Serology Test
11.3.2. Stool Antigen Test (SAT)
11.3.3. Urea Breath Test (UBT)
11.4. Market Value Forecast, by Test Method, 2017–2031
11.4.1. Laboratory-based Tests
11.4.2. Point-of-Care Tests
11.5. Market Value Forecast, by End-user, 2017–2031
11.5.1. Hospitals
11.5.2. Clinics
11.5.3. Diagnostic Laboratories
11.6. Market Value Forecast, by Country/Sub-region, 2017–2031
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Test Type
11.7.2. By Test Method
11.7.3. By End-user
11.7.4. By Country/Sub-region
12. Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Test Type, 2017–2031
12.3.1. Serology Test
12.3.2. Stool Antigen Test (SAT)
12.3.3. Urea Breath Test (UBT)
12.4. Market Value Forecast, by Test Method, 2017–2031
12.4.1. Laboratory-based Tests
12.4.2. Point-of-Care Tests
12.5. Market Value Forecast, by End-user, 2017–2031
12.5.1. Hospitals
12.5.2. Clinics
12.5.3. Diagnostic Laboratories
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Test Type
12.7.2. By Test Method
12.7.3. By End-user
12.7.4. By Country/Sub-region
13. Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Test Type, 2017–2031
13.3.1. Serology Test
13.3.2. Stool Antigen Test (SAT)
13.3.3. Urea Breath Test (UBT)
13.4. Market Value Forecast, by Test Method, 2017–2031
13.4.1. Laboratory-based Tests
13.4.2. Point-of-Care Tests
13.5. Market Value Forecast, by End-user, 2017–2031
13.5.1. Hospitals
13.5.2. Clinics
13.5.3. Diagnostic Laboratories
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Test Type
13.7.2. By Test Method
13.7.3. By End-user
13.7.4. By Country/Sub-region
14. Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Test Type, 2017–2031
14.3.1. Serology Test
14.3.2. Stool Antigen Test (SAT)
14.3.3. Urea Breath Test (UBT)
14.4. Market Value Forecast, by Test Method, 2017–2031
14.4.1. Laboratory-based Tests
14.4.2. Point-of-Care Tests
14.5. Market Value Forecast, by End-user, 2017–2031
14.5.1. Hospitals
14.5.2. Clinics
14.5.3. Diagnostic Laboratories
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Test Type
14.7.2. By Test Method
14.7.3. By End-user
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. DiaSorin S.p.A.
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Meridian Bioscience, Inc.
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Exalenz Bioscience Ltd.
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Abbott
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Thermo Fisher Scientific
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Biomerica, Inc.
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Certest Biotech S.L.
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Sekisui Diagnostics
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Coris Bioconcept
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.
15.3.10.1. Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview
List of Tables
Table 01: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Test Type, 2017–2031
Table 02: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Test Method, 2017–2031
Table 03: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 04: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Country, 2017–2031
Table 06: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Test Type, 2017–2031
Table 07: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Test Method, 2017–2031
Table 08: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 09: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Test Type, 2017–2031
Table 11: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Test Method, 2017–2031
Table 12: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 13: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Test Type, 2017–2031
Table 15: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Test Method, 2017–2031
Table 16: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 17: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 18: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Test Type, 2017–2031
Table 19: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Test Method, 2017–2031
Table 20: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Test Type, 2017–2031
Table 23: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Test Method, 2017–2031
Table 24: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) and Distribution (%), by Region, 2022–2031
Figure 02: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn), by Test Type, 2022
Figure 03: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share, by Test Type, 2022
Figure 04: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn), by Test Method, 2022
Figure 05: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share, by Test Method, 2022
Figure 06: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn), by End-user, 2022
Figure 07: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share, by End-user, 2022
Figure 08: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share, by Region, 2022
Figure 09: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value (US$ Mn) Forecast, 2023–2031
Figure 10: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Test Type, 2022–2031
Figure 11: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Test Type, 2023–2031
Figure 12: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Test Method, 2022–2031
Figure 13: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Test Method, 2023–2031
Figure 14: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by End-user, 2022–2031
Figure 15: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by End-user, 2022–2031
Figure 16: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Region, 2022–2031
Figure 17: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Region, 2022–2031
Figure 18: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2031
Figure 19: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Country, 2023–2031
Figure 20: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Country, 2022–2031
Figure 21: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Test Type, 2022–2031
Figure 22: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Test Method, 2022–2031
Figure 23: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by End-user, 2022–2031
Figure 24: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Test Type, 2023–2031
Figure 25: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Test Method, 2023–2031
Figure 26:North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by End-user, 2023–2031
Figure 27: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2031
Figure 28: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 29: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 30: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Test Type, 2022–2031
Figure 31: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Test Method, 2022–2031
Figure 32: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by End-user, 2022–2031
Figure 33: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Test Type, 2023–2031
Figure 34: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Test Method, 2023–2031
Figure 35: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by End-user, 2023–2031
Figure 36: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2031
Figure 37: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 38: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 39: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Test Type, 2022–2031
Figure 40: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Test Method, 2022–2031
Figure 41: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by End-user, 2022–2031
Figure 42: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Test Type, 2023–2031
Figure 43: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Test Method, 2023–2031
Figure 44: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by End-user, 2023–2031
Figure 45: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2031
Figure 46: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 47: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 48: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Test Type, 2022–2031
Figure 49: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Test Method, 2022–2031
Figure 50: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by End-user, 2022–2031
Figure 51: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Test Type, 2023–2031
Figure 52: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Test Method, 2023–2031
Figure 53: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by End-user, 2023–2031
Figure 54: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2031
Figure 55: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 56: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 57: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Test Type, 2022–2031
Figure 58: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Test Method, 2022–2031
Figure 59: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by End-user, 2022–2031
Figure 60: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Test Type, 2023–2031
Figure 61: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Test Method, 2023–2031
Figure 62: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by End-user, 2023–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Helicobacter Pylori (H. Pylori) Non-invasive Testing Market
